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ABSTRACT
Respiratory isolates of Pseudomonas aeruginosa were collected from 58 critically-ill patients with
ventilator-associated pneumonia. Expression of elastase and pyocyanin was assessed semi-quantita-
tively, while quorum-sensing activity was assessed by quantifying the levels of the autoinducers
N-3-oxododecanoyl-L-homoserine lactone (C12-HSL) and N-butanoyl-L-homoserine lactone (C4-HSL).
Correlations were sought between quorum-sensing activity and the expression of these two virulence
factors, and all results were compared to those obtained with the laboratory reference strains PA103, a
strain defective in quorum-sensing, and PAO1, a functional quorum-sensing strain. More than two-
thirds of clinically pathogenic isolates had increased levels of elastase and ⁄ or pyocyanin, and high
quorum-sensing activity, as assessed by autoinducer levels. However, a strong correlation between
quorum-sensing activity and virulence factor production was revealed only for elastase and not for
pyocyanin (C12-HSL ⁄ elastase, r = 0.7, p 2 · 10)9; C4-HSL ⁄ elastase, r = 0.7, p 2 · 10)9). These data
suggest that the pathogenicity of P. aeruginosa isolates from critically-ill patients with ventilator-
associated pneumonia is caused, at least in part, by an increase in elastase production regulated by
quorum-sensing, while increased pyocyanin production in these isolates may be regulated predomi-
nantly by mechanisms other than quorum-sensing.
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INTRODUCTION
Pseudomonas aeruginosa, an opportunistic human
pathogen, is the most common Gram-negative
bacterium causing nosocomial infections such as
ventilator-associated pneumonia (VAP). Further-
more, P. aeruginosa is characterised by a high
degree of clinical pathogenicity, with an attribut-
able mortality that reaches 38% in patients with
VAP [1,2]. This high pathogenicity is associated
with a wide range of mechanisms and virulence
factors [3]. The synthesis and secretion of a
number of virulence factors are controlled by
quorum-sensing (QS). QS is a bacterium-to-
bacterium signalling system that allows the
bacteria to sense their environment and coordi-
nate the expression of various genes within the
entire bacterial population [4–6].
P. aeruginosa possesses two distinct, but inter-
acting, well-characterised QS systems, las and rhl.
These systems are hierarchically superimposed,
with the las system controlling the rhl system [7].
Each of these systems comprises a homoserine
lactone synthase (LasI or RhlI, respectively), a
molecule termed an autoinducer (N-3-oxododeca-
noyl-L-homoserine lactone or C12-HSL, and
N-butanoyl-L-homoserine lactone or C4-HSL,
respectively) that is freely diffusible across bacter-
ial membranes [8], and a transcriptional activator
(LasR and RhlR, respectively) that regulates gene
transcription [9,10]. During the bacterial growth
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phase, the autoinducer levels (C12-HSL and
C4-HSL) accumulate to ﬁnally reach a critical
threshold concentration at which the autoinducer
binds to its cognate receptor, which is a transcrip-
tional activator (LasR or RhlR, respectively), lead-
ing to the induction or repression of target genes.
Among up-regulated target genes are those
leading to the secretion of extracellular virulence
factors. The las system controls the expression of
virulence factors such as LasA protease, LasB
protease (elastase), alkaline protease, exotoxin A
and LasI, while the rhl system controls the
expression of rhamnolipid, LasA protease, LasB
protease, RhlI and pyocyanin. This regulation of
virulence factor expression by QS suggests that
QS might have a major role in P. aeruginosa
pathogenicity, and virulence studies in animals
with laboratory reference strains have suggested
that the QS system is crucial in the pathogenesis
of P. aeruginosa-induced pneumonia [11–13].
However, laboratory reference strains may have
lost important pathophysiological characteristics,
and their study might therefore lead to inaccurate
or clinically irrelevant correlations [14]. Further-
more, the role of QS in clinical isolates from typical
human lung infections caused by P. aeruginosa
has not been documented.
A number of studies have focused on
QS-deﬁcient clinical isolates and investigated
their genotypic, as opposed to phenotypic, char-
acteristics [15–18], while others have focused on
isolates from cystic ﬁbrosis (CF) patients. In
clinical isolates from CF patients, P. aeruginosa
lasR transcription correlated with the transcrip-
tion of lasA, lasB and toxA, suggesting that the las
system controls virulence gene expression during
the course of this speciﬁc infection [19]. Autoin-
ducers have also been detected in sputum from
these patients [20–22], but no correlation between
autoinducer levels and virulence factor expres-
sion was revealed [20]. Relatively modest corre-
lations in transcript levels among lasR, lasB and
aprA were found in non-CF isolates from different
sources (e.g., pneumonia, water) [23], but this
correlation was observed in only 50% of the
isolates. Phenotypic characterisation of respira-
tory P. aeruginosa isolates has only been per-
formed in a single study [24], which revealed
that three of nine isolates colonising mechani-
cally-ventilated patients were defective in the
production of both autoinducers and extracellular
virulence factors. However, the number of non-
clonal isolates studied was too small to make a
correlation between autoinducers and virulence
factors. Furthermore, this study concerned only
colonised patients.
The aim of the present study was to examine the
hypothesis that clinically pathogenic P. aeruginosa
isolates from critically-ill patients with VAPwould
have increased QS activity and a resulting
increased expression of elastase and pyocyanin,
which are virulence factors considered to be
QS-regulated. The results obtainedwere compared
to those obtained with two reference laboratory
strains, PA103, a lasR mutant strain, and PAO1, a
QSwild-type strainwith high levels of autoinducer
and elastase production [25].
MATERIALS AND METHODS
Clinical isolates
P. aeruginosa clinical isolates were grown from frozen cultures
isolated originally from routine tracheal aspirate samples of
patients with VAP who were hospitalised in intensive care
units (ICUs) between February 2003 and December 2004. VAP
was deﬁned as a lower respiratory tract infection that devel-
oped after mechanical ventilation for ‡3 days. Clinical, bio-
logical or radiological criteria for pneumoniae were: new lung
opacity on two chest radiographs at >12-h intervals plus two of
the following ﬁndings: presence of either fever (temperature
‡38.2C) or hypothermia (temperature <36C), a white blood
cell count of >10 000 cells ⁄mm3 or <4000 cells ⁄mm3, and
purulent endotracheal aspirate. Quantitative microbiological
criteria were ‡104 CFU ⁄mL from bronchoalveolar lavage
ﬂuids, ‡106 CFU ⁄mL from endotracheal aspirates, or
‡103 CFU ⁄mL from protected specimen brush cultures.
Therapeutic criteria were the initiation or modiﬁcation of
antibiotic therapy. The clinical isolates were collected by the
Pyopneumagen group of 12 French university hospitals in
Angers, Caen, Lille, Paris, Roubaix and Tourcoing. The study
was approved by the institutional review boards of the
participating institutions. Samples were obtained after
informed consent of the patients or their legal representative.
Exclusion criteria were CF, neutropenia and previous lung
colonisation by P. aeruginosa. Two standard laboratory refer-
ence strains were used as controls: P. aeruginosa PA103 (ATCC
29260), which is a lasR mutant, and the wild-type strain PAO1
(ATCC 39018).
Genotypic characterisation of the isolates
The clonality of the P. aeruginosa isolates was investigated
using standard pulsed-ﬁeld gel electrophoresis (PFGE) pro-
cedures. Following overnight digestion of genomic DNA at
37C with DraI (New England Biolabs, Beverly, MA, USA),
electrophoresis was performed in agarose 1% w ⁄v gels using
a CHEF-DR III System (BioRad, Hercules, CA, USA). The
criteria of Tenover et al. [26] were used to distinguish clonal
isolates from non-clonal isolates. Unrelated isolates were
initially deﬁned as those with differences in at least three
PFGE bands.
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Determination of autoinducer concentrations
Culture supernatants were extracted with ethyl acetate, and
autoinducer concentrations were determined in bioassays
using P. aeruginosa PAO-JP2 (pECP61.5) for C4-HSL [27] and
Escherichia coli MG4 (pPCS.1) for C12-HSL [28]. In brief,
extracts were added to cultures of these bacteria, which
harboured a plasmid with a transcriptional fusion of a QS
transcriptional activator and the b-galactosidase reporter gene
lacZ, so that exogenous autoinducer resulted in induction of
b-galactosidase. Thus, b-galactosidase activity, measured as
described by Miller [29], was proportional to the autoinducer
concentration. Standard curves were constructed using known
quantities of synthetic C12-HSL or C4-HSL (Aurora Bioscienc-
es, Coralville, IA, USA). Reporter strain cultures were grown
for 14 h at 37C with shaking in Medium A (K2HPO4 10.5 g ⁄L,
KH2HPO4 4.5 g ⁄L, (NH4)2SO4 1 g ⁄L, Na3-citrate.2H2O 0.5 g ⁄L,
yeast extract 0.5 g ⁄L) [30], supplemented with ampicillin
100 mg ⁄L, glucose 0.4% w ⁄v and 1 mM MgSO4, and were
then subcultured in the same medium. Autoinducers were
added to the culture at an OD660 of 0.3, after which the cells
were incubated until an OD660 of 0.7 was reached. The culture
was then resuspended in the same volume of Medium
A supplemented with yeast extract 0.05% w ⁄v. The b-galac-
tosidase activity was assayed using 2-nitrophenyl-b-D-galac-
topyranoside (Sigma-Aldrich, Lyon, France) as described by
Miller [29].
Elastase assays
The level of LasB protease (elastase) activity in the supernatant
fraction of isolates was determined spectrophotometrically at
OD600 using an elastin Congo red assay as described
previously [27]. Absorption caused by pigments produced by
P. aeruginosa was corrected by subtracting the absorbance at
OD495 of control samples incubated in the absence of
elastin Congo red. Values were expressed as the ratio
(OD495 ⁄OD600) · 100. All assays were performed in triplicate.
Pyocyanin assays
The pyocyanin assay was based on the absorbance of pyo-
cyanin at 520 nm in an acidic solution as described previously
[31]. Values were expressed as the ratio (OD520 ⁄OD600) · 100.
All assays were performed in triplicate.
Statistical analyses
Statistical analyses were performed using Pearson’s correlation
coefﬁcient or simple linear regression. A logarithmic transfor-
mation was ﬁrst applied to C4-HSL, C12-HSL, pyocyanin and
elastase to respect the normality assumption. All statistical
analyses were performed using R software v.1.9.1 (http://
www.r-project.org) [32].
RESULTS
Collection of clinical isolates
Between February 2003 and December 2004, 58
P. aeruginosa isolates were collected from 58
patients. To avoid the collection of duplicate
isolates associated with hospital outbreaks, each
isolate was typed by PFGE. Overall, 96% of
the isolates were non-clonal (data not shown); four
epidemiologically-related proﬁles were shared by
isolates from four patients from two hospitals.
Replicate isolates were excluded from the study,
leaving 56 genotypically distinct isolates, collected
from 56 patients, for further analysis.
Levels of elastase and pyocyanin
In-vitro levels of elastase and pyocyanin
produced by the 56 non-clonal isolates were
compared with those produced by the lasR
mutant strain (PA103) [31] and a QS wild-type
strain (PAO1). Seventeen (30.3%) isolates pro-
duced less elastase than the lasR mutant strain
PA103 [33], two (3.6%) isolates produced higher
levels of elastase than PAO1, and 37 (66.1%)
isolates produced levels of elastase between those
of PA103 and PAO1 (Fig. 1a). The pyocyanin
assays revealed that 34 (60.7%) of the isolates
produced more pyocyanin than PAO1, one (1.8%)
isolate produced less pyocyanin than PA103, and
21 (37.5%) isolates produced levels between those
of PA01 and PA103 (Fig.1b). Overall, these results
suggest that P. aeruginosa isolates associated with
VAP had, on average, lower elastase activity than
PAO1, but higher pyocyanin production than
PAO1.
Autoinducer levels
To assess the QS activity in each isolate, auto-
inducer concentrations were determined and
compared with those of the lasR mutant
and wild-type reference strains. At an OD600
of 2.0 (late exponential phase), levels of
C12-HSL ranged from 1.01 · 10)8 mol ⁄L to
1.65 · 10)4 mol ⁄L, and levels of C4-HSL ranged
from 1.49 · 10)5 mol ⁄L to 6.28 · 10)3 mol ⁄L
(Fig. 2). Most isolates produced levels of C12-
HSL and C4-HSL between those of PA103 and
PAO1 (69.6% and 62.5% of the isolates, respec-
tively). Only one isolate produced more C12-HSL
than PAO1, and none produced levels of C4-HSL
equivalent to those of PAO1. The levels of C12-
HSL and C4-HSL were lower than those of PA103
for 16 (29%) and 21 (37.5%) isolates, respectively
(Fig. 2). These results mirrored those for elastase
production, suggesting that increased levels of
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elastase in clinically pathogenic strains may be
caused by QS. However, the results were not
completely superimposable on those for pyocya-
nin production, suggesting that QS via las and rhl
might not be the only system regulating the
increased levels of pyocyanin production. A
correlation analysis of these two QS components
revealed that there was a strong correlation
between C4-HSL and C12-HSL levels (r = 0.59,
p 1.3 · 10)6), which supports the known interac-
tion between these two QS systems [7,33].
Relationships between QS activity and
virulence factor levels
The pathogenicity of the clinical isolates might be
caused by increased production of QS-related
virulence factors and increased QS activity.
A strong correlation (r = 0.7; p 2 · 10)9) was
revealed between levels of elastase and las system
autoinducer (C12-HSL) in the 56 clinical isolates.
There was also a correlation (r = 0.7; p 2.2 · 10)9)
between levels of elastase and rhl system autoin-
ducer (C4-HSL) in the 56 isolates. These correla-
tions suggested that the rhl QS system might be at
least as important as the las system in regulating
elastase production.
In contrast, there was only a poor correlation
(r = 0.3; p 0.02) between pyocyanin and C4-HSL
Fig. 1. Box-plot of the production levels of quorum-sens-
ing-related virulence factors in culture supernatants from
56 non-clonal clinically pathogenic isolates of Pseudomonas
aeruginosa and comparison with laboratory reference
strains PAO1 and PA103. Logarithmic scales are used.
Dotted lines show the relative levels of production of
reference strains PAO1 and PA103. (a) Elastase production
as assessed by elastin Congo red assay, expressed as
OD495 ⁄OD600. (b) Pyocyanin production as assessed by
absorbance in an acidic solution expressed as
OD520 ⁄OD600.
Fig. 2. Production of autoinducers (a) N-3-oxododecanoyl-
L-homoserine lactone (C12-HSL) and (b) N-butanoyl-L-
homoserine lactone (C4-HSL) in culture supernatants from
56 non-clonal clinically pathogenic isolates of Pseudomonas
aeruginosa and comparison with laboratory reference
strains PAO1 and PA103. Results are expressed in lmol ⁄L
on logarithmic scales.
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levels, and no signiﬁcant correlation with
C12-HSL levels. This indicates that only the rhl
QS system may play a role in increased pyocyanin
production in these isolates. However, since there
was, at most, only a poor correlation between
HSL levels and increased pyocyanin production,
it is likely that other mechanisms were predom-
inantly responsible for regulating pyocyanin pro-
duction in these isolates.
DISCUSSION
The present study conﬁrmed the hypothesis that
most clinically pathogenic P. aeruginosa strains
associated with VAP in critically-ill patients have
increased expression of two virulence factors,
elastase and pyocyanin, which are considered to
be regulated by QS, and that, concomitantly, most
strains have increased QS activity. The fact that
such results were observed in two-thirds of the
isolates studied suggests that increased QS activ-
ity and QS-regulated virulence factor production
may play a role in the clinical pathogenicity of
P. aeruginosa.
Elastase, a metalloproteinase secreted by a
type II secretion system, has been shown to
destroy respiratory epithelium tight junctions,
leading to increased permeability disorders,
increased interleukin-8 levels and a decreased
host immune response [34,35]. Therefore, it is not
surprising that most (two-thirds) of the clinically
pathogenic isolates in the present study should
have increased levels of production of such a
virulence factor. The ﬁnding of a strong correla-
tion between QS activity and elastase levels is also
consistent with previous studies concerning the
regulation of elastase production by QS in labo-
ratory strains [10,36,37].
The remaining one-third of isolates (also path-
ogenic) had levels of elastase, C12-HSL and
C4-HSL that were lower than those of PA103,
the lasRmutant strain. This agrees with the results
of a previous study, which revealed that 33% of
P. aeruginosa isolates colonising intubated patients
were defective in the production of both auto-
inducers and extracellular virulence factors [24].
Such defective isolates often have mutational
defects in both lasR and rhlR [23,24], but the
sequences of these genes were not determined in
the present study. Although QS and elastase-
deﬁcient strains were found among these clini-
cally pathogenic isolates, this does not contradict
the theory that QS-regulated virulence may play a
role in P. aeruginosa pathogenicity, but simply
emphasises the fact that pathogenicity may be
regulated by a wide range of mechanisms [3].
The levels of pyocyanin in these clinically
pathogenic isolates were lower than those in
PA103 for only one pyocyanin-deﬁcient isolate,
with most (60.7%) isolates having pyocyanin
levels that were higher than those of the QS
wild-type strain PAO1. The high levels of pyocy-
anin production in these isolates from patients
with VAP suggest that pyocyanin may play a
major role in acute pneumonia, in agreement with
the results of studies using animal models, which
revealed an important role for pyocyanin in
oxidative-stress-related tissue damage [38,39].
However, unlike elastase, the high levels of
pyocyanin were not well-correlated with high
levels of C4-HSL, C12-HSL or elastase, which
suggests that increased production of pyocyanin
was not regulated via QS in these isolates,
although pyocyanin is considered to be regulated
by QS. Indeed, pyocyanin expression is under
RhlI control [37], which may explain the poor
correlation between pyocyanin and C4-HSL
levels. Since the las system positively regulates
expression of both rhlR and rhlI [7,40], a correla-
tion between C12-HSL and pyocyanin levels was
also sought, but was not detected. This result
indicates that, of the two QS systems las and rhl,
probably only rhl regulates pyocyanin expression.
Although most previous studies have suggested
the existence of a quasi-exclusive, direct or indi-
rect, QS-regulated control mechanism for the two
differentially regulated phenazine biosynthetic
operons involved in pyocyanin production
[41–43], it seems that other regulatory mecha-
nisms could be responsible for the increased
production of pyocyanin in these isolates [44,45].
Most previous studies have investigated labo-
ratory reference strains and, with the exception of
research concerning QS in strains infecting CF
patients, the only studies that have focused on
clinically relevant strains have concerned eye
infections [15] or lung colonisation, but not
infection, in critically-ill patients [24]. The present
study is the ﬁrst to characterise QS-related viru-
lence by a phenotypic analysis of both virulence
factor and HSL production in clinically patho-
genic isolates from patients with VAP. The fact
that P. aeruginosa is responsible for severe noso-
comial pneumonia in mechanically-ventilated
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patients [1,46,47] supports the choice of clinical
isolates from ICU patients with VAP as clinically
pathogenic strains. However, a limitation of the
present study is that the results were obtained in
in-vitro conditions, which might vary consider-
ably from conditions in vivo, where the micro-
environment in which P. aeruginosa grows may
modify the phenotypic characteristics of strains.
In conclusion, the results obtained in the present
study suggest that a QS-related increase in viru-
lence factors, e.g., elastase, may play a role in the
pathogenicity of P. aeruginosa strains causing VAP
in ICU patients. Investigations of this role could
yield new therapeutic strategies, and the results
should therefore be conﬁrmed in animal models
and future prospective clinical studies. Increased
pyocyanin production may also play a role in
clinically pathogenic strains, although regulation
of pyocyanin production may be independent of
the las and rhl QS systems. Other possible non-QS
mechanisms regulating pyocyanin production
deserve investigation as an entirely new ﬁeld of
research concerning P. aeruginosa.
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